Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

Go back to Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
(NASDAQ: EVAX) Delayed: 2.96 -0.09 (2.95%)
Previous Close $3.05    52 Week High
Open $3.09    52 Week Low
Day High $3.09    P/E N/A 
Day Low $2.93    EPS
Volume 3,354